We now know the full extent of the concern over compliance issues at Theranos’ Newark, California lab thanks to new documents TechCrunch has obtained under the Freedom of Information Act (FOIA).
The Centers for Medicare and Medicaid Services (CMS) began a federal investigation into the practices at Theranos’ main facility in Newark last fall involving erratic test results and…